Referències

1. Chan, W.-Y.; Liu, Q.-R.; Borjigin, J.; Busch, H.; Rennert, O. M.; Tease, L. A.; Chan, P.-K. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28: 1033-1039, 1989.


2. Okuda, M.; Horn, H. F.; Tarapore, P.; Tokuyama, Y.; Smulian, A. G.; Chan, P.-K.; Knudsen, E. S.; Hofmann, I. A.; Snyder, J. D.; Bove, K. E.; Fukasawa, K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103: 127-140, 2000.


3. Dalenc, F.; Drouet, J.; Ader, I.; Delmas, C.; Rochaix, P.; Favre, G.; Cohen-Jonathan, E.; Toulas, C. Increased expression of a COOH-truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells. Int. J. Cancer 100: 662-668, 2002.


4. Naoe T, Suzuki T, Kiyoi H, Urano T. Nucleophosmin: a versatile molecule associated with hematological malignancies.Cancer Sci. 2006 Oct; 97(10):963-9. Review.


5. Galkin, AV. et al. Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc Natl Acad Sci U S A. 2007 Jan 2; 104(1):270-5. Epub 2006 Dec 21


6. Marzec M, Kasprzycka M, Liu X, Raghunath PN, Wlodarski P, Wasik MA. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. Oncogene. 2007 Feb 8; 26 (6):813-21. Epub 2006 Aug.

Software i bases de dades

NCBI: http://www.ncbi.nih.gov/

Ensembl: http://www.ensembl.org/

Biomart: http://www.ensembl.org/biomart/martview

UCSC: http://genome.ucsc.edu/

Atlas of Genetics and Cytogenetics in Oncology and Haematology: http://atlasgeneticsoncology.org/

MEGA: Molecular Evolutionary Genetics Analysis

TORNA